Patent ID: 7091248

Claim:
A method of diagnosing adrenocortical disorders, comprising administering to a patient a compound having the following formula: wherein the first phenyl ring comprises one or more substituents R 1 which is a halogen selected from the group consisting of F, Cl, Br and I; R 2 and R 3 are each halogen atoms selected from the group consisting of F, Cl, Br and I; A is a single or double bond between the side chain carbon atoms; the second phenyl ring comprises an electrophilic group R 4 , which is SO 2 R 5 or a metabolic precursor, SOR 5 , NO 2 or CF 3 , where R 5 is H or a lower alkyl; and a radiolabelled substituent R 6 which is a halogen selected from the group consisting of F, Cl, Br and I, and diagnosing adrenocortical disorders on the basis of whether said compound is detected by imaging techniques.